UBS Group AG and UBS AG, through its Stamford branch, have announced the pricing terms for their previously disclosed cash tender offers for several series of outstanding notes. The announcement covers seven separate offers to purchase debt securities, each with specific terms and conditions as detailed in the Offer to Purchase dated October 30, 2025.
The reference yields and total consideration for each note series were determined at 10:00 a.m. Eastern time on November 5, 2025. Each offer is set to expire at 5:00 p.m. Eastern time on November 5, unless extended or terminated earlier. Investors who wish to withdraw their tendered notes must do so by the same deadline.
For holders using guaranteed delivery procedures, the deadline to submit documentation is expected to be 5:00 p.m. Eastern time on November 7, unless extended. Settlement dates are anticipated shortly after these deadlines; initial settlements are expected by November 7 and guaranteed delivery settlements by November 10.
Accepted noteholders will receive a cash payment equal to accrued and unpaid interest up to but not including the settlement date. However, those participating via guaranteed delivery will not receive interest payments covering the period from and including the initial settlement date.
Completion of any offer depends on certain conditions being met as outlined in the Offer to Purchase document. One key condition is that total consideration paid across all validly tendered notes does not exceed $4 billion.
UBS Investment Bank serves as Dealer Manager for these offers, while D.F. King & Co., Inc. acts as Information Agent and Tender Agent for USD-denominated offers; UBS AG fulfills this role for euro-denominated offers. Interested parties can access further details or request documents at https://clients.dfkingltd.com/UBS/.
The companies stress that this press release does not constitute an offer or solicitation regarding any securities outside what is permitted under applicable law. "None of UBS, the Dealer Managers, any fiscal agent, any paying agent or any trustee, as applicable, the Tender Agents or the Information Agent or their respective directors, employees and affiliates makes any recommendation whatsoever regarding the Offers, or any recommendation as to whether Holders should tender their Notes for purchase pursuant to the Offers," according to UBS.
"In making a decision regarding the Offers, Holders must rely on their own examination of the Offerors and the terms of the Offers, including the merits and risks involved," UBS stated in its release.
Investors are encouraged to consult with professional advisors before participating in these offers due to potential legal and financial implications.
For additional information about risks related to UBS’s operations or forward-looking statements included in this announcement, investors are directed toward recent filings with US regulators such as annual reports on Form 20-F and quarterly reports on Form 6-K.